Mandibulofacial dysostosis with alopecia is a rare genetic condition that affects facial development and hair growth. People with mandibulofacial dysostosis with alopecia often have sparse scalp hair or total alopecia, and small jaws and ears that can affect hearing. Signs are present from birth and are lifelong, but needs vary by age and severity. Care focuses on hearing support, dental and jaw care, airway and feeding management in infancy, and reconstructive options. The outlook depends on features and care, and many live into adulthood with coordinated treatment.
Overview
Mandibulofacial dysostosis with alopeciaSymptoms
Mandibulofacial dysostosis with alopecia features include small jaw and cheekbones, sparse hair and eyelashes, and ear differences and hearing loss. Cleft palate, breathing or feeding trouble can occur; early symptoms of Mandibulofacial dysostosis with alopecia are often noticed at birth.
Outlook and prognosis
Most children with mandibulofacial dysostosis with alopecia grow and learn typically, though speech, feeding, hearing, and dental needs often require ongoing care. Hearing support and airway, eye, and skin management can greatly improve daily comfort. Life expectancy is usually near typical with attentive multidisciplinary follow-up.
Causes and risk factors
Mandibulofacial dysostosis with alopecia results from a single‑gene change affecting early facial and hair development. Most cases are new (de novo) mutations; when inherited it is autosomal dominant. Family history raises risk; environmental or lifestyle causes aren’t established.
Genetic influences
Genetics are central in Mandibulofacial dysostosis with alopecia, which results from pathogenic variants in specific genes, most often EFTUD2. Inheritance can be autosomal dominant, including de novo changes. Genetic testing confirms the diagnosis and guides family planning and recurrence risk.
Diagnosis
Doctors suspect mandibulofacial dysostosis with alopecia from characteristic facial features, sparse hair, and ear differences. The diagnosis of mandibulofacial dysostosis with alopecia is confirmed by genetic tests for EFTUD2 changes; hearing tests and imaging help assess associated findings.
Treatment and drugs
Treatment for Mandibulofacial dysostosis with alopecia focuses on supportive, team-based care tailored to each person’s features. This may include hearing support (hearing aids, bone-anchored devices), airway and feeding management, dental/orthodontic care, and reconstructive surgery. Speech therapy, eye protection for incomplete eyelid closure, skin and scalp care for sparse hair, and genetic counseling are often part of long‑term care.
Symptoms
Mandibulofacial dysostosis with alopecia affects the development of the face, hair, and ears, so many families notice differences at birth or soon after. Features vary from person to person and can change over time. Early features of Mandibulofacial dysostosis with alopecia often include sparse scalp hair, a small lower jaw, and ear differences that can affect hearing.
Scalp hair may be thin, patchy, or slow to grow. In Mandibulofacial dysostosis with alopecia, eyebrows or eyelashes can also be sparse.
The lower jaw can be smaller than average, which can make the chin look set back. This may crowd the teeth and tongue, sometimes making chewing or clear speech harder.
Underdeveloped cheekbones can give the face a flatter or narrower look. This can change the facial profile and how glasses or masks fit.
Ears may be small, cupped, or set at a different angle, and the ear canals can be narrow. In Mandibulofacial dysostosis with alopecia, these differences often lead to muffled or quieter sound, especially in busy rooms. Loved ones often notice the changes first.
How people usually first notice Mandibulofacial dysostosis with alopecia?
Families often spot the first signs of mandibulofacial dysostosis with alopecia soon after birth: a small lower jaw, underdeveloped cheekbones, and sparse to absent scalp hair, eyebrows, and eyelashes. Newborn hearing screens may show hearing loss, and doctors may note down-slanting eye openings or eyelid notches, which together raise suspicion of this rare genetic condition. For many, how mandibulofacial dysostosis with alopecia is first noticed is a mix of these facial features, hair differences, and early hearing concerns that prompt referral to genetics and ear, nose, and throat specialists.
Types of Mandibulofacial dysostosis with alopecia
Mandibulofacial dysostosis with alopecia is a rare genetic condition that can look a little different from one person to another. Most people share a core pattern—facial bone differences, sparse to absent scalp hair, and sometimes hearing or eye findings—but severity can vary. Researchers describe these categories to better understand patterns of the condition. Below are the main variants discussed in the medical literature, so you can get a sense of the types of Mandibulofacial dysostosis with alopecia and how they differ.
FREM1-related variant
Changes in the FREM1 gene are the most established cause. People often have underdeveloped cheek and jaw bones, very sparse scalp hair, and sometimes airway or feeding challenges in infancy.
Integrin-pathway variant
Variants in integrin-related genes have been reported in a few families. Features can overlap with the classic form but may include differences in skin, nail, or palate development.
Atypical/overlap variant
Some families show an MFDA-like pattern without a confirmed gene, overlapping with other mandibulofacial syndromes. Symptoms don’t always look the same for everyone. In these cases, genetic testing helps clarify the specific subtype.
What genetics can tell you about symptoms
Some people with EFTUD2 gene changes develop small or underformed facial bones, ear differences with hearing loss, cleft palate, and sparse scalp hair or eyebrows. Different variants can disrupt how cells build facial structures and hair follicles during early development, leading to milder or more pronounced features.
Causes and risk factors
Mandibulofacial dysostosis with alopecia is caused by a change in the EDNRA gene that guides early face and hair development. Some risks are written in our DNA, passed down through families. Most cases happen as a new mutation with no family history, but it can be inherited in an autosomal dominant pattern. Lifestyle, diet, or exposures during pregnancy are not known to cause this condition, but overall health and care can influence how features are managed. People looking for early symptoms of Mandibulofacial dysostosis with alopecia often ask about risks, and family history is a key risk when a parent carries the gene change.
Environmental and biological risk factors
Mandibulofacial dysostosis with alopecia starts before birth, so risk factors are about what shapes early development rather than what happens later. People sometimes look for early symptoms of Mandibulofacial dysostosis with alopecia, but risk relates more to influences during conception and pregnancy. Doctors often group risks into internal (biological) and external (environmental). At this time, only a few broad factors have been tied to a higher chance, and several common exposures have not been shown to raise risk.
As paternal age increases, new changes can occur more often during sperm formation. This can raise the chance of rare conditions present from birth. The effect tends to increase gradually with age rather than at a single cutoff.
Older maternal age is clearly linked to chromosomal conditions, but a consistent link to this specific diagnosis has not been shown. If any effect exists, it appears to be small compared with other biological factors.
Certain medications or chemicals, such as high-dose isotretinoin (vitamin A derivative), can disrupt early facial development. These exposures have not been shown to increase the risk of mandibulofacial dysostosis with alopecia specifically. Any facial differences they cause represent a different condition.
Genetic risk factors
Most cases trace back to a change in a single gene that is active early in face formation and hair growth. These changes are present from conception, so early symptoms of Mandibulofacial dysostosis with alopecia often appear in infancy. Some families have more than one affected member, while many children are the first in their family because the change happened for the first time. Risk is not destiny—it varies widely between individuals.
Single-gene change: A single DNA change in a gene that guides jaw, ear, and hair-follicle development disrupts normal growth signals. This is the primary genetic cause of Mandibulofacial dysostosis with alopecia.
New (de novo) change: Many people with MFDA have a genetic change that arose for the first time in them. Parents’ genetic testing can be completely normal.
Inherited from parent: In some families, an affected parent passes the altered gene to a child. Each child then has about a 50% (1 in 2) chance of inheriting it. The exact features can differ from parent to child.
Germline mosaicism: Rarely, a parent without features has a small number of egg or sperm cells carrying the change. This can slightly raise the chance of a second child with MFDA after one affected child.
Variable features: The same gene change can lead to different features and severity, even within one family. This is known medically as variable expressivity.
Equal across sexes: MFDA affects people of all sexes because the gene is not on a sex chromosome. Risks to sons and daughters are similar in families.
Copy-number variants: In a minority of cases, a missing or extra piece of DNA that includes the disease gene can cause MFDA. Tests that check for deletions or duplications can detect this.
Testing can confirm: Gene sequencing and deletion/duplication analysis can identify the cause in most families. A confirmed result clarifies recurrence risk and supports options like prenatal or preimplantation testing.
Lifestyle risk factors
Mandibulofacial dysostosis with alopecia is a genetic condition; lifestyle habits do not cause it but can shape symptoms, day‑to‑day function, and complications. Understanding how lifestyle affects Mandibulofacial dysostosis with alopecia can help you prioritize routines that support breathing, nutrition, hearing, skin, and oral health. The elements below focus on modifiable habits that may ease management and improve quality of life.
Limited intake can worsen growth challenges and delay healing after craniofacial surgeries. Prioritizing calorie- and protein-dense foods or supplements supports growth and recovery.
Rapid or unmodified textures can increase choking or aspiration risk when palate or jaw differences affect swallowing. Using therapist-guided positioning, pacing, and texture adjustments can make meals safer and more efficient.
Inconsistent brushing and flossing increase decay and gum disease around crowded teeth or cleft-related dental differences. Meticulous daily care and fluoride use lower infection risk before and after dental or surgical procedures.
Unprotected scalp from alopecia burns easily and may scar. Daily sunscreen, hats, or scarves reduce sun damage and irritation on exposed skin.
Risk prevention
Mandibulofacial dysostosis with alopecia is a genetic condition that starts before birth, so the condition itself can’t be fully prevented. Prevention focuses on lowering risks and avoiding complications—from breathing and feeding issues in infancy to vision, hearing, and dental concerns over time. Planning ahead and regular monitoring help catch problems early and keep health on track. Some prevention is universal, others are tailored to people with specific risks.
Learn how the condition is inherited and your chance of passing it on. Discuss options like prenatal testing and IVF with embryo testing when planning a pregnancy.
High‑risk obstetric care and detailed ultrasounds can flag features that affect delivery and newborn care. Planning the birth at a center ready for airway and feeding support can reduce early complications.
Newborns with Mandibulofacial dysostosis with alopecia may have small jaws and breathing challenges, especially when sleeping. Having an airway plan and early checks for sleep apnea can prevent emergencies.
Clefts or jaw shape can make feeding hard and increase choking risk. Early help from feeding specialists and safe feeding positions can support growth and reduce aspiration.
Transmission
Mandibulofacial dysostosis with alopecia is not infectious; it can’t be caught or spread through touch, coughing, or blood. It is a genetic condition, and how Mandibulofacial dysostosis with alopecia is inherited usually follows an autosomal dominant pattern (one altered copy of the gene is enough to cause it).
If a parent lives with this condition, each child has a 50% chance of inheriting it. Many families, however, see it arise for the first time as a new genetic change in the egg or sperm, so neither parent is affected.
When to test your genes
Consider genetic testing if you or your child has facial bone differences, sparse or absent hair, and hearing issues suggestive of mandibulofacial dysostosis with alopecia. Test sooner if there’s a family history or an unexplained pattern across relatives. Early confirmation guides hearing support, airway and feeding planning, and tailored surgical and developmental care.
Diagnosis
Everyday signs often come first: a baby born with a smaller lower jaw, different ear shape, and sparse scalp hair may prompt a closer look. Specialists recognize the pattern of features seen with Mandibulofacial dysostosis with alopecia and confirm it with targeted tests. Early and accurate diagnosis can help you plan ahead with confidence. Tests also check hearing, vision, and breathing so care teams can address needs right away.
A craniofacial specialist looks closely at facial shape, jaw size, ear position, and scalp hair patterns. The overall pattern of findings can point strongly toward Mandibulofacial dysostosis with alopecia. This helps distinguish it from conditions with similar features.
Clinicians ask about relatives with similar facial features, hair findings, hearing differences, or prior diagnoses. A detailed family and health history can help clarify whether the condition may run in the family.
Genetic testing may be offered to clarify risk or guide treatment. Identifying a disease-causing change in a known gene confirms the genetic diagnosis of Mandibulofacial dysostosis with alopecia.
Low-radiation scans or X-rays can show differences in cheekbones, the lower jaw, and ear structures. These imaging findings support the diagnosis and also guide surgical planning if needed.
Stages of Mandibulofacial dysostosis with alopecia
Mandibulofacial dysostosis with alopecia does not have defined progression stages. It is a genetic condition present from birth, so features are generally set early and may change with growth but do not follow a step-by-step decline. In practice, early symptoms of Mandibulofacial dysostosis with alopecia are noticed in infancy, and diagnosis relies on a detailed exam, review of family history, and sometimes imaging or hearing tests. Genetic testing may be offered to clarify certain risks.
Outlook and prognosis
Looking ahead can feel daunting, but most children with Mandibulofacial dysostosis with alopecia grow and learn in ways that let them participate fully at home and school. Hearing loss and breathing or feeding challenges tend to drive day-to-day needs early on, and surgeries or hearing devices can make a big difference. Many people ask, “What does this mean for my future?”, and the honest answer is that most individuals reach adulthood, attend school, and build relationships, though they may need periodic procedures and ongoing therapies.
Prognosis refers to how a condition tends to change or stabilize over time. In Mandibulofacial dysostosis with alopecia, facial bone differences and sparse hair are typically lifelong, but they don’t usually worsen with age. Hearing loss is common and often stable; with timely support, language development can be strong. Breathing risks are highest in infancy and early childhood if the lower jaw and airway are small, and severe cases may require close monitoring or airway surgery.
Serious complications like life‑threatening airway blockage are uncommon with modern care, and overall life expectancy can be near typical when hearing, airway, and feeding issues are addressed early. Over time, most people develop their own routines for dental care, hearing support, and skin and scalp care, and many find that symptoms feel more manageable once a steady care plan is in place. Early symptoms of Mandibulofacial dysostosis with alopecia that affect outlook—such as noisy breathing, poor weight gain from feeding effort, or delayed speech from hearing loss—should prompt evaluation, since early care can make a real difference. Talk with your doctor about what your personal outlook might look like, including which specialists to see and how often to check hearing, dental alignment, growth, and airway as you or your child grows.
Long-term effects
Living with day-to-day differences in jaw shape, ears, and hair can influence how people eat, hear, speak, and sleep over time. Mandibulofacial dysostosis with alopecia tends to be lifelong, but the pattern of features is usually stable rather than steadily worsening. Long-term effects vary widely, and not everyone will experience the same challenges. What some describe as early symptoms of Mandibulofacial dysostosis with alopecia—such as feeding and breathing challenges in infancy—may ease as children grow, while other features continue into adulthood.
Facial bone shape often remains distinct across the lifespan. Jaw and cheek differences can influence chewing and speech sounds. Growth can change appearance but usually not the underlying pattern.
Scalp hair is sparse or absent and typically stays that way over time. Eyebrows and eyelashes may also be thin. Body hair can be reduced as well.
Differences in the outer and middle ear can cause long-standing conductive hearing loss. This may affect speech clarity and classroom listening. Severity can range from mild to severe.
A small lower jaw and narrow airway can lead to noisy breathing or sleep apnea. These issues may be most noticeable in infancy and childhood. Some continue to have snoring or daytime tiredness later on.
How is it to live with Mandibulofacial dysostosis with alopecia?
Mandibulofacial dysostosis with alopecia is a rare genetic condition, so daily life often involves coordinating multiple specialists—hearing support, vision care, dental and jaw management, and attention to skin and scalp health—while navigating social spaces where visible differences can draw unwanted attention. Many find that early hearing amplification, school accommodations, and speech therapy make communication smoother, and thoughtful sun care and gentle scalp routines reduce irritation. Family members, friends, and teachers play a big role by learning about the condition, using clear communication strategies, and focusing on strengths rather than appearance. With a supportive care team and community, people can build routines that protect health, reduce fatigue from appointments, and leave room for work, school, and the parts of life that feel most like them.
Treatment and drugs
Treatment for Mandibulofacial dysostosis with alopecia focuses on easing symptoms and supporting growth, breathing, hearing, feeding, and speech over time. Care is usually coordinated by a craniofacial team and may include hearing aids for conductive hearing loss, speech and feeding therapy, dental and orthodontic care, and, when needed, surgeries to widen the airway, rebuild the cheek or jaw bones, or repair a cleft palate. For scalp and eyebrow hair loss, options are limited, but brow shaping, cosmetic solutions, and sun protection for the scalp can help with comfort and appearance. Because this is a lifelong condition, regular follow-up is important to monitor the airway, middle ear health, nutrition, dental development, and speech progress, and to plan procedures at the safest times. Not every treatment works the same way for every person, so your doctor can help tailor the plan to your needs and goals.
Non-drug treatment
Non-drug care for Mandibulofacial dysostosis with alopecia focuses on breathing, feeding, hearing, speech, and appearance to support day-to-day life at any age. Non-drug treatments often lay the foundation for safe sleep, clearer communication, and healthy growth. Spotting early symptoms of Mandibulofacial dysostosis with alopecia can help families start supportive therapies sooner and prevent avoidable complications. Plans are individualized and may change as a child grows or an adult’s goals evolve.
Early hearing tests guide timely treatment for conductive or mixed hearing loss. Options can include bone-anchored devices, standard hearing aids, and classroom accommodations.
Speech-language therapy targets articulation, resonance, and clarity, especially if there is or was a cleft palate. Therapy also helps with social communication and confidence.
Feeding therapists teach safe positioning, pacing, and nipple or utensil choices to reduce choking and fatigue. Dietitians help maintain growth with texture changes or calorie-dense options.
Sleep studies can check for obstructive sleep apnea if snoring, pauses in breathing, or daytime sleepiness occur. Supports may include head positioning, nasal CPAP, or dental appliances at night.
Your genes may have an impact on how drugs work for you
Medications used for people with mandibulofacial dysostosis with alopecia can act differently depending on gene changes that affect drug processing or sensitivity. Genetic testing may help clinicians choose safer doses, avoid side effects, and select alternatives when standard treatments don’t fit.
Pharmacological treatments
There’s no drug that changes the course of mandibulofacial dysostosis with alopecia, so medicines focus on comfort, safety, and day‑to‑day function. Drugs that target symptoms directly are called symptomatic treatments. Medicines can help with issues like dry eyes, ear infections, reflux, skin irritation, and procedure-related pain—problems that may appear as early symptoms of mandibulofacial dysostosis with alopecia. Choices are individualized by age, overall health, and specific features.
Artificial tears such as carboxymethylcellulose or hypromellose can keep eyes comfortable during the day. At night, thicker ointments like petrolatum–mineral oil help prevent dryness if eyelids don’t fully close.
Amoxicillin is often used when an acute middle-ear infection needs antibiotics. Pain relief with acetaminophen or ibuprofen can make hearing aid use and sleep more comfortable for people with mandibulofacial dysostosis with alopecia.
Acid-suppressing medicines such as omeprazole or lansoprazole (proton pump inhibitors) or famotidine (an H2 blocker) may reduce burning and vomiting. This can support feeding and weight gain in infants and children with mandibulofacial dysostosis with alopecia.
Low-potency steroid creams like hydrocortisone 1% can calm itchy, inflamed patches if dermatitis develops. Regular emollients such as petrolatum or ceramide creams support the skin barrier on sensitive scalp areas.
Genetic influences
Many families ask whether mandibulofacial dysostosis with alopecia is inherited. In most cases, it stems from a single change in a gene that guides early development of the facial bones and hair, and reported families suggest an autosomal dominant pattern—one altered copy is enough to cause the condition. Many diagnoses occur for the first time in a family due to a new (de novo) change, but if a parent is affected, each child has about a 50% chance of inheriting it. Even with the same gene change, people can have very different features and degrees of hair growth. Genetic testing can help clarify the genetic causes of mandibulofacial dysostosis with alopecia, confirm the diagnosis, and outline the chance of the condition recurring in future pregnancies. A genetics professional can also walk you through what the results mean for you and your relatives.
Is Mandibulofacial dysostosis with alopecia genetic?
Genetics are central in Mandibulofacial dysostosis with alopecia, which results from pathogenic variants in specific genes, most often EFTUD2. Inheritance can be autosomal dominant, including de novo changes. Genetic testing confirms the diagnosis and guides family planning and recurrence risk.
Pharmacogenetics—how genetics influence drug effects
Care for Mandibulofacial dysostosis with alopecia is mostly surgical and supportive, so genetics influences treatment by guiding planning and by shaping how you respond to medicines used for pain, infection, and anesthesia. Alongside medical history and surgical planning, genetic testing can sometimes identify how your body handles certain medicines; pharmacogenetic testing for Mandibulofacial dysostosis with alopecia usually targets drug response rather than a disease-specific medication. Differences in drug-processing genes can affect pain control—some people break down codeine or tramadol very slowly and feel more side effects, while others clear them so quickly they get little relief. When antibiotics are needed, clinicians may avoid aminoglycosides such as gentamicin if a known mitochondrial gene change raises the risk of sudden, permanent hearing loss, which matters even more when ear structure already limits hearing. Before craniofacial procedures, anesthesia teams may consider testing or precautions for rare inherited reactions to anesthesia (like malignant hyperthermia) or unusually long effects from certain muscle relaxants, to choose the safest agents and doses. In short, the gene change that causes Mandibulofacial dysostosis with alopecia doesn’t usually set medication doses, but broader pharmacogenetic results can help personalize care and reduce risks during treatment.
Interactions with other conditions
Day to day, people with Mandibulofacial dysostosis with alopecia often find that ear, airway, and feeding differences can interact with common childhood illnesses. Doctors call it a “comorbidity” when two conditions occur together. Ear differences and hearing loss may be harder to manage if frequent ear infections are also in the mix, since infections can further reduce hearing and delay speech progress. Feeding and palate differences can overlap with reflux or swallowing issues, raising the chance of aspiration and chest infections, so nutrition and growth may need closer monitoring. Airway narrowing and a small jaw can link with obstructive sleep apnea; even a simple cold can make nighttime breathing tougher, and anesthesia for procedures needs extra planning across teams. Eye surface exposure from eyelid or cheek shape may pair with dry eye or allergies, leading to irritation that benefits from early eye care; in fact, early symptoms of Mandibulofacial dysostosis with alopecia can overlap with common issues like feeding trouble or ear infections, so coordinated care helps sort out what’s driving what.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of children born with small jaws, distinctive cheekbones, and sparse scalp hair, even when parents looked typical. Grandparents might recall a baby whose ears sat a bit lower or whose hair never thickened, while a cousin had similar features but milder. These shared stories hinted that Mandibulofacial dysostosis with alopecia runs in families, long before anyone could name it.
First described in the medical literature as a distinct condition in the early 2000s, it was recognized after careful comparison of facial features, hair growth, and hearing differences across several unrelated families. Earlier, many living with what we now call Mandibulofacial dysostosis with alopecia were grouped under broader craniofacial syndromes because the jaw and cheekbone changes overlap with better-known conditions. That blending made it hard to separate its unique pattern: the combination of facial bone differences with very sparse scalp hair and often sparse eyebrows or lashes.
As medical science evolved, specialists used detailed photographs, hearing tests, and bone imaging to map the full picture. This helped clinicians see that the condition could vary widely—even within the same family. One child might have feeding challenges from a very small lower jaw, while a sibling mainly had hair differences and mild ear canal changes. These careful observations set the stage for genetic research.
Advances in genetics then clarified the cause. Researchers found that changes in a gene involved in early facial development and hair follicle formation are responsible, confirming why both bone shape and hair growth are affected together. This discovery not only explained the pattern seen at the bedside, it also separated Mandibulofacial dysostosis with alopecia from look‑alike disorders that share some facial features but spare the hair, or vice versa.
Over time, descriptions became more precise. Clinicians learned to look for early symptoms of Mandibulofacial dysostosis with alopecia in infancy—such as feeding or breathing difficulties from a very small jaw—alongside the hallmark sparse hair. Hearing differences, sometimes from narrow or absent ear canals, were recognized as common and treatable with hearing support. With each decade, the medical community moved from broad labels toward a specific diagnosis that guides care and family planning.
Knowing the condition’s history helps explain why older records may use different names or group it with other craniofacial conditions. Despite evolving definitions, the central story has stayed consistent: a recognizable set of facial and hair features that can be identified early, confirmed by genetic testing, and supported with coordinated care. This clearer understanding means today’s families are more likely to receive an accurate diagnosis and practical guidance sooner.